SMXT Solarmax Technology Q4 2025 revenue rises 296 percent year over year shares climb nearly 4 percent CTXR Citius Pharma posts wider than expected Q4 2025 loss shares rise slightly even after steep earnings miss Centene Corporation CNC Institutional Buying Signals Undervalued Growth Opportunity Amid ShortTerm Headwinds iShares iBoxx High Yield Corporate Bond ETF HYG Steady Income and Capital Gains in a Supportive Credit Environment